Tuesday, April 14, 2026 1:22:31 PM
Why is the CEO afraid to “actually” uplift to OTCQB?
Good question — and the answer is pretty revealing.
Many “suspect” OTC companies could try to move to the OTCQB Venture Market but choose not to because it forces a level of transparency and discipline they often want to avoid.
Here are the real reasons 👇
I like #3, #6 and #7 myself.🤣🤣🤣
________________________________________
🔍 1. They don’t want stricter disclosure
The OTC Markets Group requires:
• Current, verified financials
• Annual management certification
• Ongoing disclosure standards
👉 Problem:
• Some OTC companies have:
o Weak accounting
o Aggressive revenue recognition
o Related-party transactions
Moving up means:
• More eyes on the numbers
• Higher risk of being exposed
________________________________________
👥 2. Independent directors = real oversight
To qualify, they must add 2 independent directors.
👉 That creates risk for questionable operators:
• Independent directors can:
o Challenge management
o Block shady deals
o Demand proper governance
Some CEOs prefer:
• A “friendly” or controlled board
• Minimal pushback
________________________________________
💸 3. It can restrict dilution practices
A lot of lower-tier OTC companies rely on:
• Heavy share issuance
• Convertible debt (“toxic financing”)
OTCQB doesn’t ban this, but:
• It becomes more visible
• It can hurt their eligibility or reputation
👉 So:
• Staying lower-tier = easier to keep diluting quietly
________________________________________
📉 4. They may not meet the requirements anyway
Some simply can’t qualify, due to:
• Stock price below $0.01
• Not current in filings
• Shell company status
• Poor financial condition
Instead of failing publicly, they:
• Avoid applying altogether
________________________________________
💰 5. Cost and effort
Uplisting isn’t free:
• Legal/accounting costs
• Application & annual fees
• Time and compliance burden
👉 For a legit company: worth it
👉 For a weak one: not worth the scrutiny
________________________________________
🎭 6. They rely on hype, not fundamentals
Some OTC stocks trade on:
• Press releases
• Promotions
• Retail speculation
Moving to OTCQB:
• Shifts focus to real performance
That can:
• Kill the story
• Hurt the stock price
________________________________________
🚨 7. Risk of failing and losing credibility
If they apply and get rejected by the OTC Markets Group:
• It’s a bad signal to investors
• Raises red flags instantly
So they avoid the risk entirely.
________________________________________
🧠 Bottom line
“Suspect” OTC companies often avoid OTCQB because it forces:
• Transparency
• Independent oversight
• Cleaner financials
• Reduced ability to manipulate the stock
👉 In short:
OTCQB limits the very behaviors that make some OTC companies “suspect” in the first place.
Good question — and the answer is pretty revealing.
Many “suspect” OTC companies could try to move to the OTCQB Venture Market but choose not to because it forces a level of transparency and discipline they often want to avoid.
Here are the real reasons 👇
I like #3, #6 and #7 myself.🤣🤣🤣
________________________________________
🔍 1. They don’t want stricter disclosure
The OTC Markets Group requires:
• Current, verified financials
• Annual management certification
• Ongoing disclosure standards
👉 Problem:
• Some OTC companies have:
o Weak accounting
o Aggressive revenue recognition
o Related-party transactions
Moving up means:
• More eyes on the numbers
• Higher risk of being exposed
________________________________________
👥 2. Independent directors = real oversight
To qualify, they must add 2 independent directors.
👉 That creates risk for questionable operators:
• Independent directors can:
o Challenge management
o Block shady deals
o Demand proper governance
Some CEOs prefer:
• A “friendly” or controlled board
• Minimal pushback
________________________________________
💸 3. It can restrict dilution practices
A lot of lower-tier OTC companies rely on:
• Heavy share issuance
• Convertible debt (“toxic financing”)
OTCQB doesn’t ban this, but:
• It becomes more visible
• It can hurt their eligibility or reputation
👉 So:
• Staying lower-tier = easier to keep diluting quietly
________________________________________
📉 4. They may not meet the requirements anyway
Some simply can’t qualify, due to:
• Stock price below $0.01
• Not current in filings
• Shell company status
• Poor financial condition
Instead of failing publicly, they:
• Avoid applying altogether
________________________________________
💰 5. Cost and effort
Uplisting isn’t free:
• Legal/accounting costs
• Application & annual fees
• Time and compliance burden
👉 For a legit company: worth it
👉 For a weak one: not worth the scrutiny
________________________________________
🎭 6. They rely on hype, not fundamentals
Some OTC stocks trade on:
• Press releases
• Promotions
• Retail speculation
Moving to OTCQB:
• Shifts focus to real performance
That can:
• Kill the story
• Hurt the stock price
________________________________________
🚨 7. Risk of failing and losing credibility
If they apply and get rejected by the OTC Markets Group:
• It’s a bad signal to investors
• Raises red flags instantly
So they avoid the risk entirely.
________________________________________
🧠 Bottom line
“Suspect” OTC companies often avoid OTCQB because it forces:
• Transparency
• Independent oversight
• Cleaner financials
• Reduced ability to manipulate the stock
👉 In short:
OTCQB limits the very behaviors that make some OTC companies “suspect” in the first place.
Bearish
Recent AITX News
- AITX’s RAD Scales Production as Q1 FY27 Shipments Exceed 100 Hardware Devices • GlobeNewswire Inc. • 06/01/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/01/2026 10:03:49 AM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 05/29/2026 07:59:11 PM
- AITX's RAD Construction Momentum Continues with Additional RIO and ROSA Orders • Newsfile • 05/28/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 10:01:57 AM
- AITX's RAD Converts Retail Security Pilot into Long Term Deployment • Newsfile • 05/27/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 10:02:09 AM
- AITX's RAD Adds 12 More RIO Minis at Massive Construction Site • Newsfile • 05/26/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/26/2026 10:01:31 AM
- Univest Securities, LLC Announces Closing of $700,000 Private Placement for its Client Artificial Intelligence Technology Solutions Inc. (OTC: AITX) • GlobeNewswire Inc. • 05/20/2026 09:30:00 PM
- AITX's RAD Signs Agreement with Global Healthcare Organization • Newsfile • 05/20/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 10:02:01 AM
- AITX’s RAD Launches SCANNA to Unlock Smarter Security from Existing Cameras • GlobeNewswire Inc. • 05/18/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 10:04:37 AM
- AITX and RAD CEO Selected as Speaker at UBC Security Forum • GlobeNewswire Inc. • 05/06/2026 12:40:00 PM
- AITX to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/04/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 10:08:36 AM
- AITX's RAD Enters Hospitality Sector with First Major Hotel Brand Order • Newsfile • 04/30/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 10:02:26 AM
- AITX's RAD Wins 16 Unit ROSA Order for Multi-Site Construction Deployment • Newsfile • 04/24/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2026 10:01:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 10:00:53 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 09:17:36 PM
- AITX's RAD Announces New Orders Reflecting Ongoing Market Demand • Newsfile • 03/12/2026 12:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 10:02:58 AM
